Erratum: A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways (Oncogene 2004) 23 (2681-2693) doi: 10.1038/sj.onc.1207432;A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways

Oncogene

Volumn 23, Issue 15, 2004, Pages 2681-2693

  Adriaenssens, Eric ^a   Mougel, Alexandra ^a   Goormachtigh, Gautier ^a   Loing, Estelle ^b   Fafeur, Véronique ^a   Auriault, Claude ^a   Coll, Jean ^a  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

^b Sedac Therapeutics   (France)

Author keywords

Apoptosis; Dominant negative; EBV; LMP1; Signal; TNF

Indexed keywords

GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LATENT MEMBRANE PROTEIN 1; MUTANT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; CONTROLLED STUDY; CYTOSTASIS; DRUG MECHANISM; EMBRYO; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR; WILD TYPE;

DNA VIRUSES; HUMAN HERPESVIRUS 4; RODENTIA;

EID: 2342514791     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207866     Document Type: Erratum

References (44)

1. Aggarwal BB. (2003). Nat. Rev. Immunol., 3, 745-756.
2. Baud V, Liu ZG, Bennett B, Suzuki N, Xia Y and Karin M. (1999). Genes Dev., 13, 1297-1308.
3. Brennan P, Floettmann JE, Mehl A, Jones M and Rowe M. (2001). J. Biol. Chem., 276, 1195-1203.
4. Brodeur SR, Cheng G, Baltimore D and Thorley-Lawson DA. (1997). J. Biol. Chem., 272, 19777-19784.
5. Cheng G and Baltimore D. (1996). Genes Dev., 10, 963-973.
6. Coffin WF, Geiger TR and Martin JM. (2003). J. Virol., 77, 3749-3758.
7. Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E and Mosialos G. (1996). Mol. Cell. Biol., 16, 7098-7108.
8. Devergne O, McFarland EC, Mosialos G, Izumi KM, Ware CF and Kieff E. (1998). J. Virol., 72, 7900-7908.
9. Eliopoulos AG and Young LS. (1998). Oncogene, 16, 1731-1742.
10. Eliopoulos AG and Young LS. (1999). Semin. Cancer Biol., 11, 435-444.
11. Eliopoulos AG, Gallagher NJ, Blake SM, Dawson CW and Young LS. (2001). J. Biol. Chem., 274, 16085-16096.
12. Floettmann JE and Rowe M. (1997). Oncogene, 15, 1851-1858.
13. Gires O, Kohlhuber F, Kilger E, Baumann M, Kieser A, Kaiser C, Zeidler R, Scheffer B, Ueffing M and Hammerschmidt W. (1999). EMBO J., 18, 3064-3073.
14. Gregory CD, Murray RJ, Edwards CF and Rickinson AB. (1988). J. Exp. Med., 167, 1811-1824.
15. Groux H, Cottrez F, Montpellier C, Quatannens B, Coll J, Stehelin D and Auriault C. (1997). Blood, 89, 4521-4530.
16. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E and Rickinson A. (1991). Cell, 65, 1107-1115.
17. Higuchi M, Kieff E and Izumi KM. (2002). J. Virol., 76, 455-459.
18. Horie R, Watanabe T, Ito K, Morishita Y, Watanabe M, Ishida T, Higashihara M, Kadin ME and Watanabe T. (2002a). Am. J. Pathol., 160, 1647-1654.
19. Horie R, Watanabe T, Morishita Y, Ito K, Ishida T, Kanegae Y, Saito I, Higashihara M, Mori S, Kadin ME and Watanabe T. (2002b). Oncogene, 21, 2493-2503.
20. Hsu H, Shu HB, Pan MG and Goeddel DV. (1996). Cell, 84, 299-308.
21. Hueber AO. (2003). Cell Death Differ., 10, 7-9.
22. Izumi KM and Kieff ED. (1997). Proc. Natl. Acad. Sci. USA, 94, 12592-12597.
23. Izumi KM, Kaye KM and Kieff ED. (1997). Proc. Natl. Acad. Sci. USA, 94, 1447-1452.
24. Izumi KM, McFarland EC, Riley EA, Rizzo D, Chen Y and Kieff E. (1999). J. Virol., 73, 9908-9916.
25. Kaye KM, Izumi KM and Kieff E. (1993). Proc. Natl. Acad. Sci. USA, 90, 9150-9154.
26. Kaykas A and Sugden B. (2000). Oncogene, 19, 1400-1410.
27. Kaykas A, Worringer K and Sugden B. (2001). EMBO J., 20, 2641-2654.
28. Kieser A, Kaiser C and Hammerschmidt W. (1999). EMBO J., 18, 2511-2521.
29. Kulwichit W, Edwards RH, Davenport EM, Baskar JF, Godfrey V and Raab-Traub N. (1998). Proc. Natl. Acad. Sci. USA, 95, 11963-11968.
30. Laherty CD, Hu HM, Opipari AW, Wang F and Dixit VM. (1992). J. Biol. Chem., 267, 24157-24160.
31. Liebowitz D, Wang D and Kieff E. (1986). J. Virol., 58, 233-237.
32. Masy E, Adriaenssens E, Montpellier C, Crepieux P, Mougel A, Quatannens B, Goormachtigh G, Faumont N, Meggetto F, Auriault C, Groux H and Coll J. (2002). J. Virol., 76, 6460-6472.
33. McWhirter SM, Pullen SS, Holton JM, Crute JJ, Kehry MR and Alber T. (1999). Proc. Natl. Acad. Sci. USA, 96, 8408-8413.
34. Park YC, Burkitt V, Villa AR, Tong L and Wu H. (1999). Nature, 398, 533-538.
35. Park YC, Ye H, Hsia C, Segal D, Rich RL, Liou HC, Myszka DG and Wu H. (2000). Cell, 101, 777-787.
36. Rickinson AB and Kieff E. (1996). Fields Virology. Fields BN, Knipe DM, Howley PM (eds) Lippincott-Raven: Philadelphia, PA, pp. 2397-2446.
37. Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR, Trowsdale J, Moss DJ and Rickinson AB. (1995). Eur. J. Immunol., 25, 1374-1384.
38. Schultheiss U, Puschner S, Kremmer E, Mak TW, Engelmann H, Hammerschmidt W and Kieser A. (2001). EMBO J., 20, 5678-5691.
39. Tsao DH, McDonagh T, Telliez JB, Hsu S, Malakian K, Xu GY and Lin LL. (2000). Cell, 5, 1051-1057.
40. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV and Boldin MP. (1999). Annu. Rev. Immunol., 17, 331-367.
41. Wang D, Liebowitz D and Kieff E. (1985). Cell, 43, 831-840.
42. Wang S, Rowe M and Lundgren E. (1996). Cancer Res., 56, 4610-4613.
43. Werneburg BG, Zoog SJ, Dang TTA, Kehry MR and Crute JJ. (2001). J. Biol. Chem., 276, 43334-43342.
44. Ye X, Mehlen P, Rabizadeh S, VanArsdale T, Zhang H, Shin H, Wang JJ, Leo E, Zapata J, Hauser CA, Reed JC and Bredesen DE. (1999). J. Biol. Chem., 274, 30202-30208.